Literature DB >> 9573090

Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis.

C R Brown1, S L Reiner.   

Abstract

Infection of inbred mouse strains with Borrelia burgdorferi results in the development of experimental Lyme arthritis. The degree of arthritic pathology has been suggested to correlate with the level of spirochete burden within tissues. To investigate this further, we infected resistant DBA/2 (DBA) and susceptible C3H/HeJ (C3H) mice in the hind footpads and monitored arthritis development for 21 days. To quantitate levels of spirochetes within tissues, we created a competitive PCR molecule containing modified ospA and fla gene segments. C3H mice developed severe arthritis of the tibiotarsal joints, while DBA mice developed only mild inflammation throughout the experimental period. At day 21, when the gross size and histologic composition of ankles revealed significant differences in arthritis between the strains, there was little difference in levels of spirochete DNA as determined by competitive PCR. Cultures of ankle tissue at day 21 were also uniformly positive in both C3H and DBA animals and contained relatively similar levels of spirochetes. These results indicate that the presence of spirochetes in the ankles of experimental animals is not sufficient for arthritis development. Since arthritic and nonarthritic animals can harbor relatively equal spirochete burdens yet retain their distinct phenotypic outcomes, an aberrant or overly exuberant immune response may be an additional requirement for pathology in arthritis-prone mice.

Entities:  

Mesh:

Year:  1998        PMID: 9573090      PMCID: PMC108164          DOI: 10.1128/IAI.66.5.2065-2071.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

2.  Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice.

Authors:  S W Barthold
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

3.  Infectious but nonpathogenic isolate of Borrelia burgdorferi.

Authors:  J F Anderson; S W Barthold; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product.

Authors:  G S Gassmann; E Jacobs; R Deutzmann; U B Göbel
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

5.  Susceptibility of laboratory rats to isolates of Borrelia burgdorferi from different geographic areas.

Authors:  S W Barthold; K D Moody; D S Beck
Journal:  Am J Trop Med Hyg       Date:  1990-06       Impact factor: 2.345

6.  Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi.

Authors:  K B Kenefick; L C Lim; J D Alder; J L Schmitz; C J Czuprynski; R F Schell
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

7.  Chronic Lyme borreliosis in the laboratory mouse.

Authors:  S W Barthold; M S de Souza; J L Janotka; A L Smith; D H Persing
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

8.  Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.

Authors:  A L Armstrong; S W Barthold; D H Persing; D S Beck
Journal:  Am J Trop Med Hyg       Date:  1992-08       Impact factor: 2.345

9.  Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.

Authors:  S W Barthold; C L Sidman; A L Smith
Journal:  Am J Trop Med Hyg       Date:  1992-11       Impact factor: 2.345

10.  Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection.

Authors:  C M Shih; S R Telford; R J Pollack; A Spielman
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more
  19 in total

Review 1.  Antibiotic treatment of Lyme borreliosis: what is the evidence?

Authors:  R Dinser; M C Jendro; S Schnarr; H Zeidler
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

2.  Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease.

Authors:  Xiaohui Wang; Ying Ma; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

4.  Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients.

Authors:  I Diterich; L Härter; D Hassler; A Wendel; T Hartung
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.

Authors:  F Lynn Sonderegger; Ying Ma; Heather Maylor-Hagan; James Brewster; Xiaosong Huang; Gerald J Spangrude; James F Zachary; John H Weis; Janis J Weis
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

6.  Genetic control of experimental lyme arthritis in the absence of specific immunity.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells.

Authors:  Charles R Brown; Victoria A Blaho; Christie M Loiacono
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease.

Authors:  Charles R Brown; Annie Y-C Lai; Steven T Callen; Victoria A Blaho; Jennifer M Hughes; William J Mitchell
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

9.  The nucleotide excision repair system of Borrelia burgdorferi is the sole pathway involved in repair of DNA damage by UV light.

Authors:  Pierre-Olivier Hardy; George Chaconas
Journal:  J Bacteriol       Date:  2013-03-08       Impact factor: 3.490

10.  Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.